Years after public outcry over the high cost of domestic health care prompted Beijing to reform its stance on the illicit trade of unapproved but authentic overseas drugs, the legal landscape remains fraught with glaring inconsistencies.

Years after public outcry over the high cost of domestic health care prompted Beijing to reform its stance on the illicit trade of unapproved but authentic overseas drugs, the legal landscape remains fraught with glaring inconsistencies.
[财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]
京公网安备 11010502034662号 
